Search

Your search keyword '"FAGIUOLI, STEFANO"' showing total 878 results

Search Constraints

Start Over You searched for: Author "FAGIUOLI, STEFANO" Remove constraint Author: "FAGIUOLI, STEFANO"
878 results on '"FAGIUOLI, STEFANO"'

Search Results

2. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation

3. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study

4. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

7. One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity

8. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

9. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

11. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database

12. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

13. THU-447 Incidence and predictors of complications following percutaneous liver biopsy: a multicenter study

14. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

15. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

16. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

17. Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study

20. Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients.

21. Outcomes of bailout use of continuous positive airway pressure in patients with severe COVID-19 respiratory failure

22. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

23. Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial

24. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

25. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

28. Diagnostic role of CD64 expression on neutrophils as biomarker for blood stream infection in liver cirrhosis: some preliminary findings.

30. Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation

31. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

32. Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

34. Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19

35. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

37. HepaDisk – A new quality of life questionnaire for HCV patients

38. Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

39. AISF position paper on HCV in immunocompromised patients

40. Dexrazoxane for rapid extended livedo reticularis-like skin reaction due to systemic epirubicin diffusion during transcatheter arterial chemoembolization procedure for hepatocellular carcinoma

41. Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients

42. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis

43. VACCINATON POLICIES IN SOLID ORGAN TRANSPLANT ADULT CANDIDATES AND RECIPIENTS

44. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients

45. A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: the 1969–1989 birth-cohort

46. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy

47. Relative enhancement and spleen volume predict clinical outcomes in primary sclerosing cholangitis

48. MAFLD (metabolic associated fatty liver disease) outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct antiviral agents

49. Clinical impact and treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after liver transplant (LT): the role of transjugular intrahepatic porto-systemic shunt (TIPS)

50. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study

Catalog

Books, media, physical & digital resources